Nonredundant roles of IL-10 and TGF-Β in suppression of immune responses to hepatic AAV-factor IX gene transfer

Molecular Therapy

Volumn 19, Issue 7, 2011, Pages 1263-1272

  Hoffman, Brad E ^a   Martino, Ashley T ^a   Sack, Brandon K ^a   Cao, Ou ^a   Liao, Gongxian ^b   Terhorst, Cox ^b   Herzog, Roland W ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BLOOD CLOTTING FACTOR 9; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; C3H MOUSE; C57BL 6 MOUSE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LIVER; LIVER CELL; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; STRAIN DIFFERENCE; VIRAL GENE DELIVERY SYSTEM;

MUS;

EID: 79959981724     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.33     Document Type: Article

References (45)

1. Gao, G, Wang, Q, Calcedo, R, Mays, L, Bell, P, Wang, L et al. (2009). Adeno-associated virus-mediated gene transfer to nonhuman primate liver can elicit destructive transgene-specific T cell responses. Hum Gene Ther 20: 930-942.
2. Niemeyer, GP, Herzog, RW, Mount, J, Arruda, VR, Tillson, DM, Hathcock, J et al. (2009). Long-term correction of inhibitor-prone hemophilia B dogs treated with liverdirected AAV2-mediated factor IX gene therapy. Blood 113: 797-806.
3. Cao, O, Hoffman, BE, Moghimi, B, Nayak, S, Cooper, M, Zhou, S et al. (2009). Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B. Mol Ther 17: 1733-1742.
4. Wang, L and Herzog, RW (2005). AAV-mediated gene transfer for treatment of hemophilia. Curr Gene Ther 5: 349-360. (Pubitemid 40895019)
5. Breous, E, Somanathan, S, Vandenberghe, LH and Wilson, JM (2009). Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver. Hepatology 50: 612-621.
6. Breous, E, Somanathan, S and Wilson, JM (2010). BALB/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver. Mol Ther 18: 766-774.
7. Dobrzynski, E, Fitzgerald, JC, Cao, O, Mingozzi, F, Wang, L and Herzog, RW (2006). Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. Proc Natl Acad Sci USA 103: 4592-4597.
8. Mingozzi, F, Liu, YL, Dobrzynski, E, Kaufhold, A, Liu, JH, Wang, Y et al. (2003). Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer. J Clin Invest 111: 1347-1356. (Pubitemid 36554705)
9. Fields, PA, Armstrong, E, Hagstrom, JN, Arruda, VR, Murphy, ML, Farrell, JP et al. (2001). Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice. Gene Ther 8: 354-361. (Pubitemid 32243465)
10. Nayak, S, Cao, O, Hoffman, BE, Cooper, M, Zhou, S, Atkinson, MA et al. (2009). Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T-cells. J Thromb Haemost 7: 1523-1532.
11. Hoffman, BE, Dobrzynski, E, Wang, L, Hirao, L, Mingozzi, F, Cao, O et al. (2007). Muscle as a target for supplementary factor IX gene transfer. Hum Gene Ther 18: 603-613. (Pubitemid 47187092)
12. Cao, O, Dobrzynski, E, Wang, L, Nayak, S, Mingle, B, Terhorst, C et al. (2007). Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer. Blood 110: 1132-1140. (Pubitemid 47281408)
13. Prochazkova, J, Fric, J, Pokorna, K, Neuwirth, A, Krulova, M, Zajicova, A et al. (2009). Distinct regulatory roles of transforming growth factor-beta and interleukin-4 in the development and maintenance of natural and induced CD4+ CD25+ Foxp3+ regulatory T cells. Immunology 128(1 Suppl): e670-e678.
14. Martino, AT, Nayak, S, Hoffman, BE, Cooper, M, Liao, G, Markusic, DM et al. (2009). Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicity. PLoS ONE 4: e6376.
15. Cooper, M, Nayak, S, Hoffman, BE, Terhorst, C, Cao, O and Herzog, RW (2009). Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer. Hum Gene Ther 20: 767-776.
16. Sanjabi, S, Zenewicz, LA, Kamanaka, M and Flavell, RA (2009). Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9: 447-453.
17. Saraiva, M and O'Garra, A (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
18. Wang, L, Cao, O, Swalm, B, Dobrzynski, E, Mingozzi, F and Herzog, RW (2005). Major role of local immune responses in antibody formation to factor IX in AAV gene transfer. Gene Ther 12: 1453-1464. (Pubitemid 41486134)
19. Presser, K, Schwinge, D, Wegmann, M, Huber, S, Schmitt, S, Quaas, A et al. (2008). Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity. J Immunol 181: 7751-7758.
20. Takaku, S, Terabe, M, Ambrosino, E, Peng, J, Lonning, S, McPherson, JM et al. (2010). Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells. Int J Cancer 126: 1666-1674.
21. Ahmadzadeh, M and Rosenberg, SA (2005). TGF-beta 1 attenuates the acquisition and expression of effector function by tumor antigen-specific human memory CD8 T cells. J Immunol 174: 5215-5223. (Pubitemid 40593159)
22. Haribhai, D, Lin, W, Edwards, B, Ziegelbauer, J, Salzman, NH, Carlson, MR et al. (2009). A central role for induced regulatory T cells in tolerance induction in experimental colitis. J Immunol 182: 3461-3468.
23. Thornton, AM, Korty, PE, Tran, DQ, Wohlfert, EA, Murray, PE, Belkaid, Y et al. (2010). Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
24. Shimizu, J, Yamazaki, S, Takahashi, T, Ishida, Y and Sakaguchi, S (2002). Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3: 135-142. (Pubitemid 34141443)
25. Cohen, AD, Schaer, DA, Liu, C, Li, Y, Hirschhorn-Cymmerman, D, Kim, SC et al. (2010). Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation. PLoS ONE 5: e10436.
26. Liao, G, Nayak, S, Regueiro, JR, Berger, SB, Detre, C, Romero, X et al. (2010). GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T-cells. Int Immunol 22: 259-270.
27. LoDuca, PA, Hoffman, BE and Herzog, RW (2009). Hepatic gene transfer as a means of tolerance induction to transgene products. Curr Gene Ther 9: 104-114.
28. Fields, PA, Kowalczyk, DW, Arruda, VR, Armstrong, E, McCleland, ML, Hagstrom, JN et al. (2000). Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Mol Ther 1: 225-235.
29. Verma, D, Moghimi, B, LoDuca, PA, Singh, HD, Hoffman, BE, Herzog, RW et al. (2010). Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice. Proc Natl Acad Sci USA 107: 7101-7106.
30. Xu, L, Gao, C, Sands, MS, Cai, SR, Nichols, TC, Bellinger, DA et al. (2003). Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B. Blood 101: 3924-3932. (Pubitemid 36857868)
31. Herbert, DR, Orekov, T, Perkins, C and Finkelman, FD (2008). IL-10 and TGFbeta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol 181: 7214-7220.
32. Dardalhon, V, Awasthi, A, Kwon, H, Galileos, G, Gao, W, Sobel, RA et al. (2008). IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 9: 1347-1355.
33. Maynard, CL, Harrington, LE, Janowski, KM, Oliver, JR, Zindl, CL, Rudensky, AY et al. (2007). Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat Immunol 8: 931-941. (Pubitemid 47300007)
34. Williams, LM and Rudensky, AY (2007). Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 8: 277-284. (Pubitemid 46745377)
35. Annoni, A, Brown, BD, Cantore, A, Sergi, LS, Naldini, L and Roncarolo, MG (2009). In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance. Blood 114: 5152-5161.
36. Sun, B, Kulis, MD, Young, SP, Hobeika, AC, Li, S, Bird, A et al. (2010). Immunomodulatory gene therapy prevents antibody formation and lethal hypersensitivity reactions in murine pompe disease. Mol Ther 18: 353-360.
37. Nelson, DR, Tu, Z, Soldevila-Pico, C, Abdelmalek, M, Zhu, H, Xu, YL et al. (2003). Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38: 859-868. (Pubitemid 37221669)
38. Schnell, MA, Zhang, Y, Tazelaar, J, Gao, GP, Yu, QC, Qian, R et al. (2001). Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 3(5 Pt 1): 708-722. (Pubitemid 32509868)
39. Fantini, MC, Becker, C, Monteleone, G, Pallone, F, Galle, PR and Neurath, MF (2004). Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25-T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 172: 5149-5153. (Pubitemid 38542009)
40. Mempel, TR, Pittet, MJ, Khazaie, K, Weninger, W, Weissleder, R, von Boehmer, H et al. (2006). Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141. (Pubitemid 44066829)
41. Dobrzynski, E, Mingozzi, F, Liu, YL, Bendo, E, Cao, O, Wang, L et al. (2004). Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. Blood 104: 969-977. (Pubitemid 39038015)
42. Miao, CH, Harmeling, BR, Ziegler, SF, Yen, BC, Torgerson, T, Chen, L et al. (2009). CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. Blood 114: 4034-4044.
43. Fields, PA, Kowalczyk, DW, Arruda, VR, Armstrong, E, McCleland, ML, Hagstrom, JN et al. (2000). Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Mol Ther 1: 225-235.
44. Manno, CS, Pierce, GF, Arruda, VR, Glader, B, Ragni, M, Rasko, JJ et al. (2006). Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12: 342-347. (Pubitemid 43355084)
45. Liu, YL, Wagner, K, Robinson, N, Sabatino, D, Margaritis, P, Xiao, W et al. (2003). Optimized production of high-titer recombinant adeno-associated virus in roller bottles. Biotechniques 34: 184-189. (Pubitemid 36070918)